@DrCanuckMD yes.. this had some initial hope.. biological plausibility, initial encouraging data. But then didn’t stand up to testing.
Curiously though it never became a flash point like ivermectin. Interesting dynamic.
Follow
@auscandoc @DrCanuckMD@med-mastodon.com
A bunch of right wingers never got the opportunity to invest in fluvoxamine. It's always a grift.
